The DETECT Nitazenes Act of 2025 directs the Department of Homeland Security's Science and Technology Directorate to partner with the Drug Enforcement Agency to develop improved detection and identification technology for dangerous synthetic drugs, specifically adding nitazenes to existing detection priorities alongside fentanyl and xylazine. Nitazenes are a growing synthetic opioid threat that can be detected in extremely low concentrations, making them particularly difficult to identify at borders and in drug interdiction efforts. The bill amends the Homeland Security Act of 2002 to formally include nitazenes in the agency's drug detection mandate, requiring enhanced technological capacity to disrupt these illicit substances. The legislation does not specify funding amounts or implementation timelines in the provided text, focusing instead on establishing the formal directive for the two agencies to collaborate on detection capabilities. This bill primarily affects federal law enforcement and border security operations, as well as public health efforts to combat the emerging nitazene drug threat.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.